Leonteq Securities’s Calliditas Therapeutics CALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,000
Closed -$34K – 1130
2020
Q4
$34K Buy
+1,000
New +$30.4K ﹤0.01% 846

Other funds holding CALT

Leonteq Securities's CALT Position: Q1 2021 in Review

Leonteq Securities sold out of Calliditas Therapeutics (CALT) in Q1 2021, closing a stake of 1,000 shares — an estimated $34K sold.

Leonteq Securities first reported a position in CALT in Q4 2020 and held it in 1 quarter. The position peaked at $34K in Q4 2020. 14 funds tracked by Wall St. Rank hold CALT as of Q1 2021.

  • Leonteq Securities reported no remaining Calliditas Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Leonteq Securities sold 1,000 Calliditas Therapeutics shares in Q1 2021, an estimated $34K.
  • Leonteq Securities first reported a position in Calliditas Therapeutics in Q4 2020 and held it in 1 quarter.
  • Leonteq Securities's Calliditas Therapeutics position peaked at $34K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held Calliditas Therapeutics as of Q1 2021.

Based on Leonteq Securities's 13F filing for Q1 2021, filed 26 Mar 2026.